The current valuation score of PDS Biotechnology Corp is 6.01, ranking 369 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.41, which is -53.30% below the recent high of -0.66 and -494.46% above the recent low of -8.39.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.